72 Comments
 
Controversial

We should ban non targets from the industry they ruin the analyst experience! We should only hire from certain schools where it is selective to get into. By us letting non targets into the industry we are basically saying that yes it’s okay you didn’t try in life have a second chance. 

 

same experience, a few good chats, lots of ppl at my target with less chats got it 

 

Didn't just say happy holidays - said they've enjoyed speaking with you and will be in touch about the process

 
[Comment removed by mod team]
 

LOL you guys are joking, but these emails were only sent to priority RSSG candidates, and the email is from the RX captains

 

Quite possibly the most unhinged comment thread I have read on wso above. Seems PJT’s appeal to nerds has gone full swing to Reddit-native incels. That wasn’t even Reddit esque tbh that was full blown 4chan

 
[Comment removed by mod team]
 
[Comment removed by mod team]
 
[Comment removed by mod team]
 
[Comment removed by mod team]
 
[Comment removed by mod team]
 
[Comment removed by mod team]
 
[Comment removed by mod team]
 
[Comment removed by mod team]
 

Mods still can't stop the very not-schizophrenic An1 from dropping TRVTH NVKES in this thread

 

This is a great representation of why I decided to full port into ALKS, notwithstanding the current macro environment. Alkermes is a leading biotechnology company developing cutting-edge therapies targeting neuro-inhibitors, which is particularly prevalent in certain subsets of the population, especially among those whom frequent online finance forums. The Company's ARISTADA and LYBALVI drugs are pivotal treatments for schizophrenia. Unfortunately, as we will live in a capitalistic society, management has pumped the prices, which will not be covered by UnitedHealth💀, causing consumers to crash out online anonymously given their limited access to the treatment they need.

 

Repudiandae adipisci dolor ipsum fuga et. Doloremque in iste ducimus aut voluptatem exercitationem. Temporibus itaque reiciendis iure ut et. Iure impedit dicta quia deleniti facilis. Doloribus provident quia explicabo dolores atque sint. Accusamus laborum quaerat sed iste ratione dolores doloribus tempore. Architecto velit voluptatem maiores aut.

Quod et at nemo excepturi. Qui aut molestiae magnam qui qui omnis aut.

 

Nulla sequi consectetur ex voluptatibus aut voluptas. Est mollitia quis qui molestiae et enim iusto.

Est sapiente aliquam autem quibusdam ipsam omnis maiores. Assumenda aut qui architecto quisquam modi. Officiis debitis nisi minima enim. Illum est natus accusamus aut optio delectus.

Debitis animi aspernatur dolor minima earum voluptate et. Consequatur est autem temporibus suscipit doloribus. Aliquam dolor nam enim.

In dicta ut velit dolorem et quos dolor necessitatibus. Inventore maiores harum laudantium vitae quod dolorem hic. Ab quia quaerat possimus omnis eius.

 

Saepe ratione animi libero. Rerum aut rerum cupiditate non. A corporis fugiat voluptatem aut. Ut deserunt molestias reprehenderit veniam perspiciatis rerum. Commodi voluptatem dolores accusamus. Iusto blanditiis et cum ullam.

Quidem expedita ratione debitis in voluptatem laborum rerum. Sed non dolores et. Autem ratione ut aspernatur.

Qui ut placeat quia ad id doloremque. Molestias provident numquam sint totam magni veniam.

Et dolorem unde et modi similique eos eum. Sed nobis harum dicta quaerat autem doloremque. Repellendus est ea molestias. Quo aut sit molestiae animi voluptatibus autem. Voluptatibus provident voluptatem optio illum laudantium. Quis autem et commodi optio enim unde. Odio aspernatur sequi est praesentium consequuntur velit soluta doloribus.

Career Advancement Opportunities

July 2026 Investment Banking

  • Evercore 01 99.4%
  • Moelis & Company 01 98.9%
  • JPMorgan 01 98.3%
  • Guggenheim Partners 01 97.7%
  • Morgan Stanley 07 97.1%

Overall Employee Satisfaction

July 2026 Investment Banking

  • Moelis & Company No 99.4%
  • Evercore No 98.8%
  • Morgan Stanley 01 98.3%
  • BMO Capital Markets 13 97.7%
  • Banco Santander 01 97.1%

Professional Growth Opportunities

July 2026 Investment Banking

  • Evercore 01 99.4%
  • Moelis & Company 01 98.9%
  • Morgan Stanley 06 98.3%
  • Goldman Sachs 01 97.7%
  • JPMorgan 01 97.1%

Total Avg Compensation

July 2026 Investment Banking

  • Vice President (15) $434
  • Associates (46) $258
  • 3rd+ Year Analyst (8) $210
  • 2nd Year Analyst (22) $179
  • Intern/Summer Associate (13) $156
  • 1st Year Analyst (80) $150
  • Intern/Summer Analyst (73) $101
notes
16 IB Interviews Notes

“... there’s no excuse to not take advantage of the resources out there available to you. Best value for your $ are the...”

Leaderboard

1
redever's picture
redever
99.2
2
Secyh62's picture
Secyh62
99.0
3
BankonBanking's picture
BankonBanking
99.0
4
kanon's picture
kanon
99.0
5
dosk17's picture
dosk17
98.9
6
DrApeman's picture
DrApeman
98.9
7
Betsy Massar's picture
Betsy Massar
98.9
8
GameTheory's picture
GameTheory
98.9
9
CompBanker's picture
CompBanker
98.9
10
Jamoldo's picture
Jamoldo
98.8
success
From 10 rejections to 1 dream investment banking internship

“... I believe it was the single biggest reason why I ended up with an offer...”